Regenerative Biomaterials, 2015 · DOI: 10.1093/rb/rbu017 · Published: January 13, 2015
Nerve diseases, including acute injuries like peripheral nerve injury (PNI) and chronic conditions such as neurodegenerative diseases, disrupt the nervous system's function, affecting memory and movement. The body's limited capacity to regenerate axonal pathways necessitates biomimetic approaches, such as grafting a bridge across lesions to promote tissue regeneration, particularly in the central nervous system (CNS) where a less inhibitory environment is crucial. Electrospinning is highlighted as a versatile and cost-effective method for creating extracellular matrix (ECM)-like nanofibrous structures, which, when combined with functionalizing cues, shows promise for nerve tissue applications and potential stem cell therapies.
Functionalized electrospun scaffolds, combined with stem cell therapy, hold promise for improving nerve regeneration in both traumatic PNI and central nerve injuries, potentially leading to better functional outcomes.
Electrosprayed micro/nanoparticles can be used as drug carriers for targeted drug delivery in the brain, offering a potential treatment approach for TBI and neurodegenerative diseases by bypassing the blood-brain barrier.
Further research is needed to bridge the gap between electrospun biomaterials for nerve repair and clinical standards, particularly for SCI and TBI, necessitating the development of tailored therapies for CNS injuries.